Discussion: 'Add-back regimens in patients using a GnRH agonist for premenstrual dysphoric disorder' by Segebladh et al.
In the roundtable that follows, clinicians discuss a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research. Article discussed: Segebladh B, Borgström A, Nyberg S, et al. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Am J Obstet Gynecol 2009;201:139.e1-8.
Jungheim
Emily S
ES
Instructor, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO.
Kenerson
Jessica J
JJ
Foyouzi-Yousefi
Nastaran
N
Allsworth
Jenifer E
JE
Marquard
Kerri L
KL
D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D011293:Premenstrual Syndrome / Q000188:drug therapy*; D011374:Progesterone / Q000627:therapeutic use*
D004967:Estrogens; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone